SB 685-FN (2020): establishing a wholesale prescription drug importation program and establishing the New Hampshire prescription drug competitive marketplace.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA: “SB 685-FN (2020): establishing a wholesale prescription drug importation program and establishing the New Hampshire prescription drug competitive marketplace.” Granite Record, https://graniterecord.org/bill/2020/sb685. Accessed 24 Oct. 2026.
APA: Granite Record. (n.d.). SB 685-FN (2020): establishing a wholesale prescription drug importation program and establishing the New Hampshire prescription drug competitive marketplace. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/sb685
Chicago: Granite Record. “SB 685-FN (2020): establishing a wholesale prescription drug importation program and establishing the New Hampshire prescription drug competitive marketplace.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/sb685.
BibTeX: @misc{bill-2020-sb685, title = {SB 685-FN (2020): establishing a wholesale prescription drug importation program and establishing the New Hampshire prescription drug competitive marketplace.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/sb685}, note = {Accessed 24 Oct. 2026} }

SB 685-FN (2020)

establishing a wholesale prescription drug importation program and establishing the New Hampshire prescription drug competitive marketplace.

Status: Died on the table
Term: 2019-2020
Senate committee: Commerce
Subject: Miscellaneous

The Story

It was introduced on January 8, 2020 and referred to the Senate Commerce committee. The committee held a public hearing on January 21, 2020. The committee voted unanimously, 5–0, to recommend that the Senate pass it with changes (amendment 2020-1074s), and the report was placed on the consent calendar. On March 11, 2020 the Senate adopted “Special Order to 03/12/2020, Without Objection”. The committee's amendment (2020-1074s) was adopted on a voice vote on March 12, 2020, changing the text of the bill. On March 12, 2020 the Senate voted to pass it with changes, then referred it on to the Senate Finance committee. On June 16, 2020 the Senate adopted “Vacated from Committee and Laid on Table” on a voice vote. The bill died on the table under Senate Rule 3-23 at adjournment on September 16, 2020, having been set aside and never taken back up.

Hearings and Sessions

January 21, 2020, 1:00 PM: hearing, Senate Commerce, SH 100

Votes

March 12, 2020, Senate: Ought to Pass with Amendment — yeas 24, nays 0, passed
June 16, 2020, Senate: Vacated from Committee and Laid on Table — voice vote, passed

The Docket

January 8, 2020: Introduced 01/08/2020 and Referred to Commerce
January 21, 2020: Hearing: 01/21/2020, Room 100, SH, 01:00 pm
March 11, 2020: Committee Report: Ought to Pass with Amendment #2020-1074s , 03/11/2020; Vote 5-0; CC
March 11, 2020: Sen. Morse Moved to Remove SB 685 from the Consent Calendar; 03/11/2020
March 11, 2020: Special Order to 03/12/2020, Without Objection, MA; 03/11/2020
March 12, 2020: Committee Amendment #2020-1074s , AA, VV; 03/12/2020
March 12, 2020: Ought to Pass with Amendment 2020-1074s, RC 24Y-0N, MA; Refer to Finance Rule 4-5; 03/12/2020
June 16, 2020: Vacated from Committee and Laid on Table, MA, VV; 06/16/2020
September 16, 2020: Inexpedient to Legislate, Senate Rule 3-23, Adjournment 09/16/2020

Laws It Would Change

RSA 21-I

Related Bills

HB 1280-FN (2020): relative to copayments for insulin, establishing a wholesale prescription drug importation program, establishing a New Hampshire prescription drug affordability board, establishing the prescription drug competitive marketplace, relative to the pricing of generic prescription drugs, relative to prior authorization for prescription drug coverage, and requiring insurance coverage for epinephrine auto-injectors.